Robert Susman

Insider Reports History

Location
151 W 42 St, 14 Th Floor, New York, NY
Signature
/s/ Christopher Van Tuyl, Attorney-in-Fact for Robert Susman
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Robert Susman:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Immunovant, Inc. Director Common Stock 25K $367K $14.68 May 1, 2025 Direct
Immunovant, Inc. Director Stock Option (Right to Buy) 35.2K May 1, 2025 Direct

Insider Reports Filed by Robert Susman

Symbol Company Period Transactions Value $ Form Type Date Filed Role
IMVT Immunovant, Inc. May 1, 2025 2 $0 4 May 5, 2025 Director
IMVT Immunovant, Inc. Apr 18, 2025 0 $0 3 Apr 28, 2025 Director